The Quinapril Ischemic Event Trial (QUIET): evaluation of chronic ace inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function-Reference-Cited by-同舟云学术

The Quinapril Ischemic Event Trial (QUIET): evaluation of chronic ace inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

Published:2001-05 Issue:9 Volume:87 Page:1058-1063
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Pitt Bertram,O’Neill Blair,Feldman Robert,Ferrari Roberto,Schwartz Leonard,Mudra Harald,Bass Theodore,Pepine Carl,Texter Michele,Haber Harry,Uprichard Andrew,Cashin-Hemphill Linda,Lees Robert S

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet;Becker;J Cardiovasc Pharmacol,1991

2. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study;Mancini;Circulation,1996

3. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study);Anderson;J Am Coll Cardiol,2000

4. Effects of captopril on atherosclerosis in cynomolgus monkeys;Aberg;J Cardiovasc Pharmacol,1990

5. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit;Chobanian;Hypertension,1990

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for chronic coronary disease: A brief guide for clinicians;npj Cardiovascular Health;2024-06-04

2. The ABCs of the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease;Clinical Cardiology;2024-05

3. Pathogenesis of Macrovascular Complications in Diabetes;Textbook of Diabetes;2024-01-12

4. Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk;Scientific Reports;2023-12-27

5. The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines;American Journal of Cardiovascular Drugs;2023-09-05